The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A Multi-center Study in Iran

Authors

  • Jalal Azmandian Department of Nephrology, Shafa hospital, Kerman University of Medical Sciences, Kerman, Iran Author
  • zahra shafii Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran Author
  • Shahrokh Ezzatzadegan Jahromi Department of Internal Medicine, School of Medicine Nephrourology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Author
  • Nader Nourimajalan Division of Nephrology, Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Author
  • Shiva Seyrafian Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Abdolamir Atapour Isfahan kidney diseases research center, Isfahan University of medical sciences, khorshid Hospital, Isfahan, Iran Author
  • Shahnaz Atabak Department of Medicine, Modares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author
  • Saeideh Mazloomzadeh Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran Author
  • Zeinab Norouzi Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran Author
  • Iraj Najafi Nephrology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran Author

Abstract

The pandemic of COVID-19 emerged in December 2019. Although numerous features of the illness have been investigated, the impact of disease on those patients with underlying diseases, is still a major problem. The aim of this multicenter, cohort study, was to determine the clinical manifestations of COVID-19 in peritoneal dialysis (PD) patients. Five hundred and five patients, receiving PD, were enrolled in this study, out of which 3.7% had coronavirus infection. Fever was the most common symptom (63.2%). The hospitalization rate was 10.5, 21.1% required admission to intensive care units (ICU) and the mortality rate was 21%. The most common cause of infection included close contact with the infected individuals and lower rates of protective equipment use. Although the incidence of COVID-19 among PD patients is low, the severity of the disease and the mortality rate are quite high. Vaccination and adherence to preventive measures are strongly recommended in PD patients.

 

DOI: 10.52547/ijkd.7147

Downloads

Download data is not yet available.

Downloads

Published

2022-09-30

Issue

Section

BRIEF COMMUNICATION | Dialysis

How to Cite

The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A Multi-center Study in Iran. (2022). Iranian Journal of Kidney Diseases, 16(5), 280-283. https://www.ijkd.org/index.php/ijkd/article/view/7147

Most read articles by the same author(s)

<< < 1 2 3 4